In the enzymatic models, both extracts exhibited moderate collagenase inhibition (53.9–55.0%), high hyaluronidase inhibition (64.5–76.5%) and low tyrosinase inhibition (11.1–12.7%), evidencing their potential to modulate processes associated with the degradation of the extracellular matrix and the degradation of hyaluronic acid during aging, with less effect on skin depigmentation. Here, TYR is linked to neoplasm.